In this prospective study of over 11,000 individuals with newly diagnosed type 2 diabetes, elevated YKL-40 levels were a strong prognostic biomarker for obesity-related and gastrointestinal cancers, mainly driven by liver cancer. This evidence concerns the gene CHI3L1 and liver cancer.